Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥5m2023-01-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥8m2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Operating income−¥445m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income−¥644m2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax−¥444m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax−¥2.0bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥656m2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)−¥444m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥2.0bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥656m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income−¥444m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income−¥656m2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥4.0bnat 2023-03-31Cons.Assets IFRS
Total assets¥4.4bnat 2022-12-31Cons.Assets IFRS
Total assets¥4.3bnat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥443mat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥470mat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.6bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.9bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥3.6bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥4.2bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.6bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.6bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥3.7bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥3.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.0bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥383m2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥2.1bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥580m2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1m2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥505m2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥241m2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥50m2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥1.4bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥33m2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-8.092023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-40.922022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-14.32022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-8.092023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-40.922022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-14.32022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio89.0%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio89.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 368
ItemContextValueUnit
Subtotal ope cf IFRSCurrentYTDDuration-380248000JPY
Interest paid ope cf IFRSPrior1YTDDuration-3108000JPY
Interest paid ope cf IFRSCurrentYTDDuration-2349000JPY
Net cash provided by used in operating activities IFRSPrior1YTDDuration-579987000JPY
Net cash provided by used in operating activities IFRSCurrentYTDDuration-382597000JPY
Interest received inv cf IFRSPrior1YTDDuration980000JPY
Interest received inv cf IFRSCurrentYTDDuration4800000JPY
Purchase of other financial assets inv cf IFRSPrior1YTDDuration-581342000JPY
Purchase of other financial assets inv cf IFRSCurrentYTDDuration-JPY
Maturities of marketable securities available for sale inv cf IFRSPrior1YTDDuration314593000JPY
Maturities of marketable securities available for sale inv cf IFRSCurrentYTDDuration-JPY
Purchase of property plant and equipment inv cf IFRSPrior1YTDDuration-248000JPY
Purchase of property plant and equipment inv cf IFRSCurrentYTDDuration-6243000JPY
Collection of lease receivable inv cf IFRSPrior1YTDDuration24954000JPY
Collection of lease receivable inv cf IFRSCurrentYTDDuration-JPY
Net cash provided by used in investing activities IFRSPrior1YTDDuration-241063000JPY
Net cash provided by used in investing activities IFRSCurrentYTDDuration-1443000JPY
Proceeds from issuance of shares fin cf IFRSPrior1YTDDuration-JPY
Proceeds from issuance of shares fin cf IFRSCurrentYTDDuration62601000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-32994000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-12207000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-32994000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration50394000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration97914000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration7000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-756130000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration-333639000JPY
Cash and cash equivalents IFRSPrior2YearInstant3977312000JPY
Cash and cash equivalents IFRSPrior1YearInstant4048969000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant3221182000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant3715330000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-05-12
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第9期第1四半期(自 2023年1月1日 至 2023年3月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)窪田製薬ホールディングス株式会社
Company name in english cover pageFilingDateInstantKubota Pharmaceutical Holdings Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役会長、社長兼最高経営責任者  窪田 良
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区霞が関三丁目7番1号
Telephone number address of registered headquarter cover pageFilingDateInstant03-6550-8928
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役、最高事業責任者 市川 今代
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区霞が関三丁目7番1号
Telephone number nearest place of contact cover pageFilingDateInstant03-6550-8928
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役、最高事業責任者 市川 今代
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE32854
Fund codeFilingDateInstant-
Security codeFilingDateInstant45960
Filer name in japaneseFilingDateInstant
Original text (Japanese)窪田製薬ホールディングス株式会社

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass